These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

557 related items for PubMed ID: 19855238

  • 1. Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
    Opelz G, Daniel V, Naujokat C, Döhler B.
    Transplantation; 2009 Oct 27; 88(8):962-7. PubMed ID: 19855238
    [Abstract] [Full Text] [Related]

  • 2. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A, Jiménez L, Aranda I, Alvarez L, González M, Rocamora N, Olivares J.
    Nefrologia; 2002 Oct 27; 22(5):463-9. PubMed ID: 12497748
    [Abstract] [Full Text] [Related]

  • 3. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?
    Saghafi H, Qorashi M, Heidari A.
    Transplant Proc; 2009 Sep 27; 41(7):2761-3. PubMed ID: 19765428
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus replication and "herpesvirus burden" as risk factor of cardiovascular events in the first year after renal transplantation.
    Gómez E, Laurés A, Baltar JM, Melón S, Díez B, de Oña M.
    Transplant Proc; 2005 Nov 27; 37(9):3760-3. PubMed ID: 16386530
    [Abstract] [Full Text] [Related]

  • 5. Simultaneous monitoring by real-time polymerase chain reaction of epstein-barr virus, human cytomegalovirus, and human herpesvirus-6 in juvenile and adult liver transplant recipients.
    Ono Y, Ito Y, Kaneko K, Shibata-Watanabe Y, Tainaka T, Sumida W, Nakamura T, Kamei H, Kiuchi T, Ando H, Kimura H.
    Transplant Proc; 2008 Dec 27; 40(10):3578-82. PubMed ID: 19100443
    [Abstract] [Full Text] [Related]

  • 6. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
    Jacobsen N, Badsberg JH, Lönnqvist B, Ringdén O, Volin L, Rajantie J, Nikoskelainen J, Keiding N.
    Bone Marrow Transplant; 1990 Jun 27; 5(6):413-8. PubMed ID: 2164434
    [Abstract] [Full Text] [Related]

  • 7. Risk factors for posttransplant lymphoproliferative disorder in pediatric liver transplant recipients with cytomegalovirus antigenemia.
    Kim JM, Lee SK, Kim SJ, Joh JW, Kwon CH, Choe YH, Shin M, Kim EY, Moon JI, Jung GO, Choi GS.
    Transplant Proc; 2010 Apr 27; 42(3):895-9. PubMed ID: 20430199
    [Abstract] [Full Text] [Related]

  • 8. Subclinical cytomegalovirus and Epstein-Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation.
    Li L, Chaudhuri A, Weintraub LA, Hsieh F, Shah S, Alexander S, Salvatierra O, Sarwal MM.
    Pediatr Transplant; 2007 Mar 27; 11(2):187-95. PubMed ID: 17300499
    [Abstract] [Full Text] [Related]

  • 9. The impact of pretransplant cytomegalovirus infection on acute renal allograft rejection.
    Chen JH, Mao YY, He Q, Wu JY, Lv R.
    Transplant Proc; 2005 Dec 27; 37(10):4203-7. PubMed ID: 16387078
    [Abstract] [Full Text] [Related]

  • 10. Surveillance of Epstein-Barr virus loads in adult liver transplantation: associations with age, sex, posttransplant times, and transplant indications.
    Schaffer K, Hassan J, Staines A, Coughlan S, Holder P, Tuite G, McCormick AP, Traynor O, Hall WW, Connell J.
    Liver Transpl; 2011 Dec 27; 17(12):1420-6. PubMed ID: 21837744
    [Abstract] [Full Text] [Related]

  • 11. HLA-DQ3 is a probable risk factor for CMV infection in high-risk kidney transplant patients.
    Varga M, Rajczy K, Telkes G, Hídvégi M, Péter A, Remport A, Korbonits M, Fazakas J, Toronyi E, Sárváry E, Kóbori L, Járay J.
    Nephrol Dial Transplant; 2008 Aug 27; 23(8):2673-8. PubMed ID: 18332066
    [Abstract] [Full Text] [Related]

  • 12. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N, Wannstedt C, Keyes L, Wagener MM, Cacciarelli TV.
    Liver Transpl; 2005 Jun 27; 11(6):700-4. PubMed ID: 15915496
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus & Epstein Barr Virus serostatus as a predictor of the long-term outcome of kidney transplantation.
    Le Page AK, Mackie FE, McTaggart SJ, Kennedy SE.
    Nephrology (Carlton); 2013 Dec 27; 18(12):813-9. PubMed ID: 23927085
    [Abstract] [Full Text] [Related]

  • 14. [CMC and EBV infections in children].
    Polz-Dacewicz M, Stec A, Koncewicz R.
    Przegl Epidemiol; 2002 Dec 27; 56(1):65-72. PubMed ID: 12150069
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients.
    Shahinian VB, Muirhead N, Jevnikar AM, Leckie SH, Khakhar AK, Luke PP, Rizkalla KS, Hollomby DJ, House AA.
    Transplantation; 2003 Mar 27; 75(6):851-6. PubMed ID: 12660514
    [Abstract] [Full Text] [Related]

  • 16. Detection of viral DNA in kidney graft preservation and washing solutions is predictive of posttransplant infections in pediatric recipients.
    Barzon L, Murer L, Pacenti M, Biasolo MA, Vella MD, Ghirardo G, Gamba PG, De Arias AE, Zanon GF, Palù G.
    J Infect Dis; 2009 Nov 01; 200(9):1425-33. PubMed ID: 19803803
    [Abstract] [Full Text] [Related]

  • 17. Determination of risk factors for Epstein-Barr virus-associated posttransplant lymphoproliferative disorder in pediatric liver transplant recipients using objective case ascertainment.
    Guthery SL, Heubi JE, Bucuvalas JC, Gross TG, Ryckman FC, Alonso MH, Balistreri WF, Hornung RW.
    Transplantation; 2003 Apr 15; 75(7):987-93. PubMed ID: 12698085
    [Abstract] [Full Text] [Related]

  • 18. Epstein-Barr virus in pediatric patients after renal transplantation.
    Schwab M, Böswald M, Korn K, Ruder H.
    Clin Nephrol; 2000 Feb 15; 53(2):132-9. PubMed ID: 10711415
    [Abstract] [Full Text] [Related]

  • 19. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec 15; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 15; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.